Independent Advisor Alliance Makes New $106,000 Investment in PetMed Express, Inc. (NASDAQ:PETS)

Independent Advisor Alliance bought a new position in PetMed Express, Inc. (NASDAQ:PETS) during the 3rd quarter, HoldingsChannel.com reports. The fund bought 28,891 shares of the company’s stock, valued at approximately $106,000.

A number of other large investors have also made changes to their positions in PETS. Point72 DIFC Ltd acquired a new position in PetMed Express in the 2nd quarter worth approximately $34,000. Price T Rowe Associates Inc. MD grew its holdings in shares of PetMed Express by 48.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 129,229 shares of the company’s stock valued at $620,000 after buying an additional 42,125 shares in the last quarter. Squarepoint Ops LLC acquired a new position in PetMed Express during the second quarter valued at $273,000. SG Americas Securities LLC purchased a new position in PetMed Express during the 2nd quarter valued at about $46,000. Finally, Vanguard Group Inc. boosted its holdings in shares of PetMed Express by 0.8% during the first quarter. Vanguard Group Inc. now owns 1,186,485 shares of the company’s stock worth $5,683,000 after purchasing an additional 9,226 shares during the period. Institutional investors and hedge funds own 73.33% of the company’s stock.

Analysts Set New Price Targets

PETS has been the subject of a number of research reports. StockNews.com raised shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th. Lake Street Capital restated a “hold” rating and issued a $3.50 target price (down previously from $7.00) on shares of PetMed Express in a research note on Wednesday, August 7th.

PetMed Express Trading Down 1.5 %

PetMed Express stock opened at $4.63 on Friday. PetMed Express, Inc. has a 1-year low of $2.90 and a 1-year high of $7.90. The firm’s fifty day simple moving average is $4.26 and its 200-day simple moving average is $3.96. The company has a market capitalization of $95.67 million, a P/E ratio of -77.17 and a beta of 0.68.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.17. The company had revenue of $59.57 million during the quarter, compared to analysts’ expectations of $66.02 million. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%. On average, equities research analysts predict that PetMed Express, Inc. will post 0.24 earnings per share for the current year.

Insider Buying and Selling at PetMed Express

In other news, major shareholder Nina Capital Holdings Inc. acquired 12,500 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was acquired at an average cost of $3.34 per share, with a total value of $41,750.00. Following the acquisition, the insider now owns 2,078,000 shares in the company, valued at approximately $6,940,520. This represents a 0.61 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.10% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.